Gi-Young Sohn
Vorstandsvorsitzender bei ENZYCHEM LIFESCIENCES CORPORATION
Vermögen: 6 Mio $ am 30.04.2024
Aktive Positionen von Gi-Young Sohn
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ENZYCHEM LIFESCIENCES CORPORATION | Direktor/Vorstandsmitglied | - | - |
| Vorstandsvorsitzender | 01.06.2012 | - | |
| Vorsitzender | 01.06.2012 | - | |
Bridget Lifesciences Corp.
 Bridget Lifesciences Corp. Financial ConglomeratesFinance Bridget Lifesciences Corp. functions as an investment holding South Korean company. Hye-Kyung Kim has been the CEO of the private company since 2003. | Vorsitzender | 01.01.2003 | - |
Karriereverlauf von Gi-Young Sohn
Ausbildung von Gi-Young Sohn
| Korea University | Graduate Degree |
Statistik
International
| Südkorea | 4 |
Operativ
| Chairman | 2 |
| Director/Board Member | 1 |
| Chief Executive Officer | 1 |
Sektoral
| Consumer Services | 2 |
| Health Technology | 2 |
| Finance | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ENZYCHEM LIFESCIENCES CORPORATION | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Bridget Lifesciences Corp.
Bridget Lifesciences Corp. Financial ConglomeratesFinance Bridget Lifesciences Corp. functions as an investment holding South Korean company. Hye-Kyung Kim has been the CEO of the private company since 2003. | Finance |
- Börse
- Insiders
- Gi-Young Sohn
- Erfahrung
